US Stock MarketDetailed Quotes

PRME Prime Medicine

Watchlist
  • 1.660
  • -0.030-1.78%
Trading Apr 28 15:42 ET
217.73MMarket Cap-1.01P/E (TTM)

Prime Medicine Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
25.72%-122.87M
137.03%16.25M
33.84%-25.91M
-11.44%-45.49M
-62.91%-67.71M
-25.48%-165.41M
-42.82%-43.86M
-30.13%-39.17M
-101.85%-40.82M
18.18%-41.56M
Net income from continuing operations
1.14%-195.88M
35.60%-42.28M
-3.57%-52.52M
-30.53%-55.33M
-16.15%-45.76M
-62.64%-198.13M
-67.10%-65.64M
-72.77%-50.71M
-44.42%-42.39M
-65.26%-39.4M
Operating gains losses
----
----
----
----
----
250.00%28K
----
----
----
----
Depreciation and amortization
31.70%6.13M
37.69%1.72M
26.05%1.56M
37.57%1.54M
25.00%1.32M
109.22%4.65M
43.33%1.25M
95.88%1.24M
160.00%1.12M
259.04%1.05M
Deferred tax
--0
--0
--0
-532.26%-134K
166.34%134K
71.06%-279K
--0
-150.94%-108K
107.01%31K
62.03%-202K
Other non cash items
-3.39%12.36M
-34.05%2.21M
401.59%15.73M
-357.16%-8.93M
18.26%3.35M
30.62%12.79M
19.66%3.35M
13.21%3.14M
41.93%3.47M
59.49%2.83M
Change In working capital
1,074.01%31.08M
238.13%48.86M
49.06%3.58M
256.66%8.75M
-249.48%-30.11M
107.48%2.65M
1,133.99%14.45M
162.34%2.4M
-456.70%-5.59M
74.87%-8.62M
-Change in prepaid assets
-67.73%-15.86M
-1,440.48%-6.39M
-85.70%-6.95M
106.85%275K
-117.43%-2.79M
-444.02%-9.46M
36.93%-415K
-260.75%-3.74M
-1,098.21%-4.01M
-540.07%-1.29M
-Change in payables and accrued expense
-169.33%-16.91M
-87.34%2.32M
-171.81%-6.06M
382.22%10.69M
-424.29%-23.86M
204.20%24.4M
304.78%18.29M
1,625.97%8.44M
-42.46%2.22M
85.90%-4.55M
-Change in other current liabilities
47.45%-6.46M
86.75%-454K
85.43%-335K
41.66%-2.21M
-24.49%-3.46M
-19.98%-12.3M
-27.40%-3.43M
30.30%-2.3M
-94.26%-3.79M
-20.49%-2.78M
-Change in other working capital
--70.31M
---1.61M
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
25.72%-122.87M
137.03%16.25M
33.84%-25.91M
-11.44%-45.49M
-62.91%-67.71M
-25.48%-165.41M
-42.82%-43.86M
-30.13%-39.17M
-101.85%-40.82M
18.18%-41.56M
Investing cash flow
Cash flow from continuing investing activities
265.86%68.46M
16.88%48.25M
233.29%50.34M
-75.26%6.89M
-192.40%-37.03M
139.73%18.71M
401.64%41.29M
-179.55%-37.77M
154.85%27.86M
-141.00%-12.67M
Net PPE purchase and sale
16.39%-7.29M
2.66%-1.79M
56.10%-1.28M
3.74%-1.9M
-16.26%-2.32M
45.80%-8.72M
61.78%-1.84M
39.28%-2.91M
58.85%-1.98M
-18.42%-2M
Net investment purchase and sale
170.79%74.75M
15.40%49.77M
245.99%50.9M
-70.69%8.8M
-225.41%-34.71M
191.00%27.61M
586.08%43.13M
-299.78%-34.86M
166.32%30.01M
-132.82%-10.67M
Net other investing changes
688.24%1M
--276K
----
----
----
74.44%-170K
--0
--0
----
----
Cash from discontinued investing activities
Investing cash flow
265.86%68.46M
16.88%48.25M
233.29%50.34M
-75.26%6.89M
-192.40%-37.03M
139.73%18.71M
401.64%41.29M
-179.55%-37.77M
154.85%27.86M
-141.00%-12.67M
Financing cash flow
Cash flow from continuing financing activities
29,804.73%195.88M
-99.48%1K
12,011.01%38.51M
-53.33%35K
231,263.24%157.33M
-99.64%655K
-99.89%194K
146.56%318K
112.02%75K
105.35%68K
Net common stock issuance
--170.14M
--0
--38.08M
--0
--132.06M
--0
--0
--0
--0
--0
Proceeds from stock option exercised by employees
2,913.74%19.74M
-99.48%1K
35.85%432K
-53.33%35K
28,241.18%19.27M
199.09%655K
24.36%194K
404.76%318K
--75K
--68K
Net other financing activities
--6M
--0
--0
--0
--6M
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
29,804.73%195.88M
-99.48%1K
12,011.01%38.51M
-53.33%35K
231,263.24%157.33M
-99.64%655K
-99.89%194K
146.56%318K
112.02%75K
105.35%68K
Net cash flow
Beginning cash position
-72.62%55.07M
129.81%132.04M
-48.46%69.1M
-26.74%107.66M
-72.62%55.07M
1.29%201.12M
-6.49%57.46M
26.80%134.07M
-17.15%146.96M
1.29%201.12M
Current changes in cash
196.87%141.47M
2,804.36%64.5M
182.15%62.94M
-199.28%-38.56M
197.10%52.59M
-5,780.51%-146.05M
-101.71%-2.39M
-72.98%-76.62M
82.01%-12.89M
-155.80%-54.16M
End cash Position
256.89%196.54M
256.89%196.54M
129.81%132.04M
-48.46%69.1M
-26.74%107.66M
-72.62%55.07M
-72.62%55.07M
-6.49%57.46M
26.80%134.07M
-17.15%146.96M
Free cash flow
25.25%-130.16M
131.63%14.45M
35.38%-27.19M
-10.74%-47.39M
-60.77%-70.03M
-17.72%-174.14M
-28.65%-45.7M
-20.60%-42.08M
-71.02%-42.8M
17.00%-43.56M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 25.72%-122.87M137.03%16.25M33.84%-25.91M-11.44%-45.49M-62.91%-67.71M-25.48%-165.41M-42.82%-43.86M-30.13%-39.17M-101.85%-40.82M18.18%-41.56M
Net income from continuing operations 1.14%-195.88M35.60%-42.28M-3.57%-52.52M-30.53%-55.33M-16.15%-45.76M-62.64%-198.13M-67.10%-65.64M-72.77%-50.71M-44.42%-42.39M-65.26%-39.4M
Operating gains losses --------------------250.00%28K----------------
Depreciation and amortization 31.70%6.13M37.69%1.72M26.05%1.56M37.57%1.54M25.00%1.32M109.22%4.65M43.33%1.25M95.88%1.24M160.00%1.12M259.04%1.05M
Deferred tax --0--0--0-532.26%-134K166.34%134K71.06%-279K--0-150.94%-108K107.01%31K62.03%-202K
Other non cash items -3.39%12.36M-34.05%2.21M401.59%15.73M-357.16%-8.93M18.26%3.35M30.62%12.79M19.66%3.35M13.21%3.14M41.93%3.47M59.49%2.83M
Change In working capital 1,074.01%31.08M238.13%48.86M49.06%3.58M256.66%8.75M-249.48%-30.11M107.48%2.65M1,133.99%14.45M162.34%2.4M-456.70%-5.59M74.87%-8.62M
-Change in prepaid assets -67.73%-15.86M-1,440.48%-6.39M-85.70%-6.95M106.85%275K-117.43%-2.79M-444.02%-9.46M36.93%-415K-260.75%-3.74M-1,098.21%-4.01M-540.07%-1.29M
-Change in payables and accrued expense -169.33%-16.91M-87.34%2.32M-171.81%-6.06M382.22%10.69M-424.29%-23.86M204.20%24.4M304.78%18.29M1,625.97%8.44M-42.46%2.22M85.90%-4.55M
-Change in other current liabilities 47.45%-6.46M86.75%-454K85.43%-335K41.66%-2.21M-24.49%-3.46M-19.98%-12.3M-27.40%-3.43M30.30%-2.3M-94.26%-3.79M-20.49%-2.78M
-Change in other working capital --70.31M---1.61M--------------------------------
Cash from discontinued investing activities
Operating cash flow 25.72%-122.87M137.03%16.25M33.84%-25.91M-11.44%-45.49M-62.91%-67.71M-25.48%-165.41M-42.82%-43.86M-30.13%-39.17M-101.85%-40.82M18.18%-41.56M
Investing cash flow
Cash flow from continuing investing activities 265.86%68.46M16.88%48.25M233.29%50.34M-75.26%6.89M-192.40%-37.03M139.73%18.71M401.64%41.29M-179.55%-37.77M154.85%27.86M-141.00%-12.67M
Net PPE purchase and sale 16.39%-7.29M2.66%-1.79M56.10%-1.28M3.74%-1.9M-16.26%-2.32M45.80%-8.72M61.78%-1.84M39.28%-2.91M58.85%-1.98M-18.42%-2M
Net investment purchase and sale 170.79%74.75M15.40%49.77M245.99%50.9M-70.69%8.8M-225.41%-34.71M191.00%27.61M586.08%43.13M-299.78%-34.86M166.32%30.01M-132.82%-10.67M
Net other investing changes 688.24%1M--276K------------74.44%-170K--0--0--------
Cash from discontinued investing activities
Investing cash flow 265.86%68.46M16.88%48.25M233.29%50.34M-75.26%6.89M-192.40%-37.03M139.73%18.71M401.64%41.29M-179.55%-37.77M154.85%27.86M-141.00%-12.67M
Financing cash flow
Cash flow from continuing financing activities 29,804.73%195.88M-99.48%1K12,011.01%38.51M-53.33%35K231,263.24%157.33M-99.64%655K-99.89%194K146.56%318K112.02%75K105.35%68K
Net common stock issuance --170.14M--0--38.08M--0--132.06M--0--0--0--0--0
Proceeds from stock option exercised by employees 2,913.74%19.74M-99.48%1K35.85%432K-53.33%35K28,241.18%19.27M199.09%655K24.36%194K404.76%318K--75K--68K
Net other financing activities --6M--0--0--0--6M--------------------
Cash from discontinued financing activities
Financing cash flow 29,804.73%195.88M-99.48%1K12,011.01%38.51M-53.33%35K231,263.24%157.33M-99.64%655K-99.89%194K146.56%318K112.02%75K105.35%68K
Net cash flow
Beginning cash position -72.62%55.07M129.81%132.04M-48.46%69.1M-26.74%107.66M-72.62%55.07M1.29%201.12M-6.49%57.46M26.80%134.07M-17.15%146.96M1.29%201.12M
Current changes in cash 196.87%141.47M2,804.36%64.5M182.15%62.94M-199.28%-38.56M197.10%52.59M-5,780.51%-146.05M-101.71%-2.39M-72.98%-76.62M82.01%-12.89M-155.80%-54.16M
End cash Position 256.89%196.54M256.89%196.54M129.81%132.04M-48.46%69.1M-26.74%107.66M-72.62%55.07M-72.62%55.07M-6.49%57.46M26.80%134.07M-17.15%146.96M
Free cash flow 25.25%-130.16M131.63%14.45M35.38%-27.19M-10.74%-47.39M-60.77%-70.03M-17.72%-174.14M-28.65%-45.7M-20.60%-42.08M-71.02%-42.8M17.00%-43.56M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Intel
INTC
20.560
Oracle
ORCL
140.395
Netflix
NFLX
1110.525
4
Apple
AAPL
210.748
5
Meta Platforms
META
549.935
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀